Evidence map›Paper›PMID 29054361›Full record

ArticleBioorganic & medicinal chemistry letters2017

Metastatic melanoma imaging using a novel Tc-99m-labeled lactam-cyclized alpha-MSH peptide.

Liqin Liu, Jingli Xu, Jianquan Yang, Changjian Feng, Yubin Miao

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Science translational medicine · 2018
    Article
  3. The Value of Technetium-99m Labeled Alpha-Melanocyte-Stimulating Hormone (Asia Oceania journal of nuclear medicine & biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Liqin LiuSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, PR China.
Jingli XuDepartment of Radiology, University of Colorado Denver, Aurora, CO 80045, USA.
Jianquan YangDepartment of Radiology, University of Colorado Denver, Aurora, CO 80045, USA.
Changjian FengCollege of Pharmacy, University of New Mexico, Albuquerque, NM 87131, USA.
Yubin MiaoDepartment of Radiology, University of Colorado Denver, Aurora, CO 80045, USA. Electronic address: yubin.miao@ucdenver.edu.
University of Colorado Denver · USUniversity of New Mexico · USUniversity of Science and Technology Beijing · CN

Funding

Novel Receptor-Targeting Theranostic Peptides for Prostate CancerR15CA173516 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI FENG, CHANGJIAN · 2013 to 2013
$453k
NCI NIH HHS R15 CA173516
6 · The paper itself

Abstract

The purpose of this study was to determine the metastatic melanoma imaging property of

Indexed as

alpha-MSHAnimalsCell Line, TumorLactamsMelanoma, ExperimentalMiceMice, Inbred C57BLNiacinamidePeptides, CyclicRadiopharmaceuticalsTechnetiumTissue DistributionTomography, Emission-Computed, Single-PhotonTransplantation, Homologousalpha-MSHhydrazinonictinamideLactamsNiacinamidePeptides, CyclicRadiopharmaceuticalsTechnetium(99m)Tc-labeled lactam-cyclized peptideAlpha-melanocyte stimulating hormoneMetastatic melanoma imaging

Identifiers

PMID29054361
PMCPMC5667642
OpenAlexW2762701632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.